VCBeat Health
Contact Us
Home
China Healthcare Select
Insights
MNC China Lens
Vertical Industries
Services
Partnership Development
Market Entry Advisory
Ecosystem Engagement Advisory
About VCBeat
Why VCBeat
Log In
Home
ApolloBio and INOVIO Announce Positive Topline Results from Pivotal Phase 3 Trial of VGX-3100 in HPV-16/18-Associated Cervical Dysplasia
ApolloBio and INOVIO Announce Positive Topline Results from Pivotal Phase 3 Trial of VGX-3100 in HPV-16/18-Associated Cervical Dysplasia
May 22, 2026 04:05 CST Updated 04:26
Share:
